Ledger.Open graph →
SEC Form D · filed December 21, 2011

Ember Therapeutics, Inc

Offering
$34.2M
Sold
$3.2M
Exemption
—
Industry
Biotechnology
Location
BOSTON, MA
Type
—

People & firms on this filing (8)

Mitchell S. Bloom · Boston, MAExecLouis Tartaglia · Boston, MAExec · DirectorKevin Gillis · Stone Mountain, GAExecPeter Flint · Waltham, MAExecLouis Tartaglia · San Francisco, CAExec · DirectorKevin Gillis · Boston, MAExecBruce Spiegelman · Boston, MADirectorDan Lynch · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗